創新醫療(002173.SZ)旗下建華醫院派出醫療隊支援湖北孝感
格隆匯2月12日丨創新醫療(002173.SZ)公佈，近日，根據黑龍江省委、省政府和齊齊哈爾市委、市政府統一部署，經公司指示，公司全資子公司齊齊哈爾建華醫院有限責任公司(“建華醫院”)作為黑龍江省齊齊哈爾市唯一一家民營三甲醫院，組建醫療隊承擔了黑龍江省齊齊哈爾市第三批援助湖北孝感的任務。建華醫院醫療隊於2020年2月12日出發前往湖北省孝感市，全力支援孝感市開展新型冠狀病毒感染的肺炎醫療救治工作。
建華醫院於近日收到《黑龍江省衞生健康委關於組派第三批醫療隊援助湖北孝感應對新型冠狀病毒感染肺炎疫情的通知》，黑龍江省全力支援湖北省孝感市開展新型冠狀病毒感染肺炎的醫療救治工作，將組派第三批醫療隊援助湖北省孝感市應對新型冠狀病毒感染肺炎疫情。公司對此高度重視，指示全資子公司建華醫院積極響應，選派出20名醫護人員支援湖北省孝感市的抗擊疫情工作。此次派出醫療隊由6名醫生和14名護士組成，由建華醫院副主任醫師孫沛帶隊於2020年2月12日出發前往湖北省孝感市。
疫情就是命令，防控就是責任。公司及全資子公司建華醫院積極響應政府號召，派出的醫療隊將在本次支援孝感抗擊疫情的戰鬥中擔負起醫務工作者的使命和責任，發揚艱苦奮鬥精神，充分展現公司醫務人員良好的專業素養和職業形象，全力幫助支援地打好疫情防控攻堅戰。
面對新型冠狀病毒肺炎疫情防控的嚴峻形勢，公司高度關注疫情發展並積極履行社會責任。本次全資子公司建華醫院響應政府部門號召，在相關政府部門的統一協調下派出醫療隊支援湖北省孝感市應對新型冠狀病毒感染肺炎疫情，是公司作為一家公眾上市公司積極承擔社會責任的體現，有利於全資子公司建華醫院提升當地的影響力，也提升了公司的資本市場形象。
公司將持續關注派出醫療隊的工作情況，並盡最大努力做好相關醫務人員的後勤保障工作，盡全力保障公司的醫務人員完成任務平安歸來。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
